Axon Therapies

New York, NY · Founded 2014 · Privately Held (backing)

Developer of a healthcare device designed to reduce sympathetic nerve activity and address the root cause of heart failure. Axon Therapies is based in New York, NY and was founded in 2014. It was valued at $44.5 million at its later-stage round in Jan 2021, the last priced event on record. It has raised $75.8 million across 3 recorded rounds; the latest was a $7.5 million early-stage round in Jan 2019.

PMV mark · valuation
$44.5M
Oct 2026
Priced at
its later-stage round
Jan 2021
Total raised
$75.8M
Last round
Early Stage VC
Jan 2019
What is Axon Therapies worth?
$44.5MPrivateMarketView mark · Oct 2026

Valued at $44.5M at its later-stage round, Jan 2021. Nothing has traded since.

Free account
More of Axon Therapies with a free account
  • ·Watch Axon Therapies: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Axon Therapies funding history

3 rounds
DateRoundRaisedPost-money
Jan 2019Early Stage VC$7.5M▮
Jun 2017Seed Round$1.3M▮
Apr 2016Seed Round$2.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Axon Therapies valuation

Axon Therapies was valued at $44.5 million at its later-stage round in Jan 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Axon Therapies raised?

Axon Therapies has raised $75.8 million in total; 3 of its rounds are on record, from 2016 on. The largest on record was a $7.5 million early-stage round in Jan 2019.

Axon Therapies has filed 4 Form Ds with the SEC since 2016, most recently in Feb 2019 ($7.5 million sold to 10 investors).

How Axon Therapies's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Axon Therapies, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Axon Therapies

What is Axon Therapies worth?
Axon Therapies is valued at $44.5M as of Oct 2026. Valued at $44.5M at its later-stage round, Jan 2021. Nothing has traded since.
How much has Axon Therapies raised?
Axon Therapies has raised $75.8M in total funding across 3 recorded rounds.
When did Axon Therapies last raise?
Axon Therapies last raised in Jan 2019 (Early Stage VC), raising $7.5M.